LifeVantage Appoints Chief Marketing Officer

LifeVantage Appoints Chief Marketing Officer

David Toda, President LifeVantage Japan and Former Chief Marketing Officer
Amway Japan Appointed Global Chief Marketing Officer

SALT LAKE CITY, Aug. 7, 2013 (GLOBE NEWSWIRE) -- LifeVantage Corporation
(Nasdaq:LFVN), a company dedicated to helping people achieve healthy living
through a combination of a compelling business opportunity and scientifically
validated products, announced today that David Toda, the company's President
of LifeVantage Japan and General Manager Asia Pacific has accepted a role as
global Chief Marketing Officer for the company. Mr. Toda will retain his
responsibilities as General Manager Asia Pacific, overseeing operations in
Asia, but will relinquish day-to-day control of the company's operations in
Japan. Effective immediately, LifeVantage will begin a search for a country
manager to oversee day-to-day sales and operations in Japan.

Mr. Toda has a deep background in marketing and management. Prior to joining
LifeVantage, Mr. Toda served as Vice President, Chief Marketing Officer of
Amway Japan from March 2011 to October 2012.Prior to joining Amway Japan, Mr.
Toda served in a variety of capacities with Quicksilver Japan, including as
President and Representative Director.Before Quicksilver Japan, Mr. Toda was
Chief Marketing Officer of Adidas Japan K.K.Prior to joining Adidas Japan
K.K., Mr. Toda served in management positions with Nike, Inc., J. Walter
Thompson Japan Limited and Visa International Asia-Pacific.Mr. Toda holds a
Bachelor of Arts degree in Economics from the University of Washington.

"We are excited to have David take a more global role with the company and to
lead our world-wide marketing efforts.His experience guiding global brands is
impressive and we believe he will add even more value to LifeVantage in this
role.We appreciate David accepting this opportunity to take LifeVantage to
the next level and believe he has the strategic and tactical acumen to
continue to elevate our marketing efforts," said Douglas C. Robinson,
President and CEO.

"I am convinced that we have a great opportunity to continue our growth in the
coming years.I believe that my extensive marketing experience will allow me
to take the company's brands to a new level of recognition and significance in
the global market," commented Mr. Toda. "I am very excited to be given the
opportunity to apply my experience even more broadly than in the role in Japan
and Asia Pacific."

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq:LFVN), a leader in Nrf2 science and the maker
of Protandim®, the Nrf2 Synergizer® patented dietary supplement, TrueScience®
Anti-Aging Cream and LifeVantage^® Canine Health, is a science-based
nutraceutical company.LifeVantage is dedicated to visionary science that
looks to transform wellness and anti-aging internally and externally with
products that dramatically reduce oxidative stress at the cellular level. The
Company was founded in 2003 and is headquartered in Salt Lake City, Utah.

Forward Looking Statements

This document contains forward-looking statements made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act of 1995.
Words and expressions reflecting optimism and satisfaction with current
prospects, as well as words such as "believe," "anticipates," "look forward
to," "should" and variations thereof, identify forward-looking statements, but
their absence does not mean that a statement is not forward-looking. Examples
of forward-looking statements include, but are not limited to, statements we
make regarding our anticipated growth and expansion of operations and our
growth potential worldwide. Such forward-looking statements are not guarantees
of performance and the Company's actual results could differ materially from
those contained in such statements. These forward-looking statements are based
on the Company's current expectations and beliefs concerning future events
affecting the Company and involve known and unknown risks and uncertainties
that may cause the Company's actual results or outcomes to be materially
different from those anticipated and discussed herein. These risks and
uncertainties include, among others, the Company's inability to successfully
expand our operations in existing and other markets and thereafter manage our
growth; the Company's ability to retain independent distributors or to attract
new independent distributors on an ongoing basis; the Company's ability to
expand its product offerings; violations of law or our procedures by the
Company's independent distributors; the potential for third-party and
governmental actions involving the Company's network marketing efforts; the
potential for product liability claims against the Company; the risk that
government regulators and regulations could adversely affect the Company's
business; future laws or regulations may hinder or prohibit the production or
sale of the Company's existing product and any future products; unfavorable
publicity could materially hurt the Company's business; the Company's ability
to access raw materials for its products as it grows; and the Company's
ability to protect its intellectual property rights and the value of its
products. These and other risk factors are discussed in greater detail in the
Company's Annual Report on Form 10-K and its Quarterly Report on Form 10-Q
under the caption "Risk Factors," and in other documents filed by the Company
from time to time with the Securities and Exchange Commission. The Company
cautions investors not to place undue reliance on the forward-looking
statements contained in this document. All forward-looking statements are
based on information currently available to the Company on the date hereof,
and the Company undertakes no obligation to revise or update these
forward-looking statements to reflect events or circumstances after the date
of this document, except as required by law.

CONTACT: Investor Relations Contact:
         Cindy England 801.432.9036
         Director of Investor Relations
         John Mills 310.954.1105
         Senior Managing Director, ICR, LLC

company logo
Press spacebar to pause and continue. Press esc to stop.